Close Menu


The institute has purchased 22 new Genome Analyzers for its biomedical research programs.

The one-year program will cultivate community relations and aim to enhance knowledge about genomics and genetics research and issues.

Founded in 2000 on technology developed at the Ontario Cancer Institute and University of Toronto, Molecular Templates had difficulty securing add-on funding in its home country following a $1.5 million investment earlier this decade.

The industry standards issued last December by 23andMe, Decode, and Navigenics are "a good start, but they are really not where they need to be," said Muin Khoury, director of the CDC's Office of Public Health Genomics.

Wageningen UR will use the company's genomic sequencing technology in its efforts to map the potato's genetic code.

The company is in the late stages of closing a Series D investment, but due to the slowdown of the capital markets in recent months, "it has taken us longer than anticipated to close," a company official said.

After going through a restructuring phase at the end of last year in which it temporarily laid off its entire staff, LightSpeed continues to develop its optical detection technology and plans to test it with a new sequencing chemistry this year.

In Print: Apr 14, 2009


Microarray-Related Papers of Note Published in March 2009

Frank Witney, Paul Keim, Trilochan Sahoo, Jack Lord, Mari Baker, Patrick Terry, Lutz Kirchrath

NextBio will use the funds to develop its vertebrate and plant information platform for cross-species research.


IBM security researchers warn of a phishing campaign targeted at organizations involved in the distribution of SARS-CoV-2 vaccines, the Verge reports.

The Illinois police have cut the number of DNA tests waiting to be run in about half, CBS Chicago reports.

A researcher accused of smuggling research materials out of the US has pleaded guilty to making false statements, according to the Associated Press.

In Science this week: gene expression signature linked to nonalcoholic fatty liver disease progression, and more.